China Drug Screening Market Overview, 2031

China has the world's most populous country, with a vast workforce. The demand for drug screening testing is often tied to employment, and a large workforce necessitates comprehensive screening programs for various industries. China has experienced rapid economic growth and industrialization over the past few decades. With a booming economy and diverse industries, there is a heightened need for drug screening in workplaces to ensure a safe and productive workforce. The rise in substance abuse issues in China has led to increased awareness and the implementation of drug testing programs, both in workplaces and educational institutions. Pre-employment drug screening has become standard practice in many industries. With China's focus on maintaining a high-quality workforce, employers is increasingly incorporating drug testing into their hiring processes. China has witnessed significant growth in its pharmaceutical industry. As the pharmaceutical sector expands, there is a parallel need for drug screening testing to ensure the safety and integrity of pharmaceutical products and processes. China has been actively investing in research and development across various sectors, including healthcare and diagnostics. This investment has led to the development of new and more sophisticated drug screening technologies, contributing to the overall growth of the market. With the rise of precision medicine, there is an increased emphasis on tailoring healthcare interventions, including drug treatments, to individual characteristics. Drug screening plays a crucial role in identifying individuals who may have adverse reactions to specific medications, aligning with the broader trend of precision medicine in China.
According to the research report, "China Drug Screening market Overview, 2031," published by Bonafide Research, the China Drug Screening market is anticipated to grow at more than 12.22% CAGR from 2026 to 2031.The Chinese government has been investing heavily in drug screening in recent years, and the country now has one of the largest and most comprehensive drug screening programs in the world. The program includes mandatory testing for all employees of state-owned enterprises, as well as random testing for students, military personnel, and other high-risk groups. China uses a variety of drug screening methods to detect drug use, including urine tests, hair tests, and blood tests. Urine tests are the most common method, but hair tests can detect drug use for a longer period of time, and blood tests can detect drug use even if the drug has been taken recently. China has a strict legal framework for drug screening, and violators can face serious penalties, including fines, imprisonment, and even execution. The government also has a policy of "zero tolerance" for drug use, and drug users are often stigmatized and ostracized. The Chinese government has also been using drug screening to target ethnic minorities and other marginalized groups. These high-risk groups include people who have a history of drug use, people who are known to associate with drug users, and people who are employed in occupations that are considered to be high-risk for drug use, such as transportation, construction, and entertainment. One challenge is the large size of the Chinese population. Another challenge is the stigma associated with drug use in China. People who test positive for drug use may face discrimination and social isolation. Precision medicine, also known as personalized medicine, is an approach to healthcare that takes into account individual differences in genes, environment, and lifestyle to tailor treatment plans. China is using precision medicine to improve the effectiveness of drug treatment for people with substance use disorders.

The drug screening market in China is shaped by a dynamic mix of consumables, analytical instruments, rapid testing devices, and drug screening services, reflecting the country’s rapid industrial growth, expanding healthcare infrastructure, and increasing regulatory oversight. Consumables are the most widely used segment, primarily due to their recurring need in routine drug testing across hospitals, occupational health programs, laboratories, and law enforcement initiatives. Reagents, assay kits, test strips, and sample collection materials are in constant demand, making consumables a key revenue driver. Analytical instruments, including high-precision technologies such as gas chromatography, liquid chromatography, and mass spectrometry, play a critical role in confirmatory testing, forensic applications, and quality-controlled laboratory environments. However, their high costs and technical requirements restrict widespread adoption to specialized facilities. Rapid testing devices are gaining traction in China, particularly in workplace settings, roadside enforcement, and decentralized healthcare assessments. These devices offer portability, ease of use, and immediate preliminary results, making them ideal for situations where speed is crucial. Despite the growing adoption of instruments and devices, drug screening services dominate the market in terms of overall utilization, as many organizations prefer outsourcing testing to certified providers. Professional services manage the entire process, from sample collection to laboratory analysis and compliance reporting, ensuring accuracy, efficiency, and adherence to China’s strict regulatory framework.

In China, drug screening is conducted using urine, breath, hair, oral fluid, and other specialized samples, each meeting unique clinical, occupational, and forensic requirements. Urine samples are the leading sample type, widely adopted for their cost-effectiveness, reliability, and long-established acceptance in workplace, healthcare, and legal testing programs. Urine testing is particularly preferred for pre-employment screening, random testing, post-incident investigations, and substance abuse monitoring, as it enables detection of multiple substances within a reasonable detection window. Breath samples are primarily utilized for alcohol testing, with law enforcement and transportation authority’s relying on them for real-time impairment assessment. Their scope is limited to alcohol but they remain essential for traffic safety programs. Hair samples are increasingly employed for forensic and long-term substance use monitoring, providing a historical record of drug exposure. However, higher costs and longer processing times limit their routine adoption. Oral fluid samples are gaining popularity in China due to their non-invasive collection, ease of supervision, and strong correlation with recent drug use, making them suitable for roadside testing and workplace screenings. Other sample types, such as blood and sweat, are mostly used in specialized clinical and forensic contexts requiring high analytical precision. Despite the growth of alternative sample types, urine-based testing continues to dominate the Chinese market, supported by regulatory familiarity, practicality, and cost efficiency.

The end-user landscape of China’s drug screening market includes drug testing laboratories, hospitals and clinics, and other organizations such as corporate employers, law enforcement agencies, and government institutions. Drug testing laboratories are the leading end users, forming the backbone of the country’s drug screening infrastructure. These laboratories handle high testing volumes, perform confirmatory analyses, and operate under strict accreditation and regulatory standards, making them the preferred choice for workplace compliance, forensic investigations, and judicial cases. Hospitals and clinics represent an important segment, particularly in emergency care, addiction treatment, and mental health services. Drug screening in these settings supports diagnosis, patient monitoring, and treatment planning. However, hospital-based testing tends to be more targeted and case-specific rather than high-volume or routine. The “others” segment includes corporate workplaces, occupational health providers, and public sector organizations, especially in safety-sensitive industries such as manufacturing, transportation, and logistics. Many of these organizations rely on external laboratories or certified service providers to ensure accuracy, efficiency, and regulatory compliance rather than maintaining in-house testing capabilities. With increasing awareness of substance abuse, workplace safety, and public health initiatives, drug testing laboratories remain the dominant end-user segment in China, supported by their technical expertise, scalability, and ability to provide accurate, reliable, and legally defensible results.

"Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031
Aspects covered in this report
• Drug Screening Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation
By Product and Service
• Consumables
• Analytical Instruments
• Rapid Testing Devices
• Drug Screening Service



By Sample Type
• Urine Samples
• Breath Samples
• Hair Samples
• Oral Fluid Samples
• Other Samples

By End User
• Drug Testing Laboratories
• Hospitals & Clinics
• Others "